| Size & multiples | |||
| Market Cap | $11.58B | Enterprise Value | $13.50B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 2.88× | P/FCF | 29.60× |
| EV/EBITDA | 32.11× | EV/EBIT | 191.84× |
| EV/Sales | 3.35× | EV/FCF | 34.51× |
| FCF Yield | 3.38% | Buyback Yield | 1.86% |
| Owner Earnings (TTM) | -$50.3M | Owner Earnings Yield | −0.43% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.35 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 10.76% |
| After-tax Cost of Debt | — | Synthetic credit rating | CC |
| Cost of Debt · embedded (pre-tax) | 4.96% | Cost of Debt · marginal (synthetic) | 16.61% |
| WACC | — | ROIC | 0.37% |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$2.91 · revenue TTM $4.03B · FCF TTM $391.3M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on EV/EBITDA
EV/EBITDA 78th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| EV/EBITDA | 26.5x | 15.1x | 9.8x–24.4x | 78 ↑rich |
| FCF Yield | 4.5% | -7.8% | -34.7%–1.4% | 85 ↑strong |
| Net Margin | -3.6% | -21.2% | -325.3%–7.2% | 62 ↑strong |
| Operating Margin | 0.6% | -34.5% | -552.0%–8.0% | 67 ↑strong |
| ROE | -4.4% | -36.8% | -92.5%–4.5% | 70 ↑strong |
